| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1998;32:1049-1053.)
© 1998 American Heart Association, Inc.
Scientific Contributions |
From the Walter Reed Army Medical Centers (L.P.Y.) and Georgetown University Medical Center, Washington, DC.
Correspondence to Dr Pedro A. Jose, Georgetown University Medical Center 2-PHC, 3800 Reservoir Rd NW, Washington, DC 20007. E-mail josep{at}gunet.georgetown.edu
AbstractDopamine, via
D1-like receptors, stimulates the activity of both protein
kinase A (PKA) and protein kinase C (PKC), which results in inhibition
of renal sodium transport. Since D1-like receptors
differentially regulate sodium transport in normotensive and
hypertensive rats, they may also differentially regulate PKC expression
in these rat strains. Thus, 2 different D1-like agonists
(fenoldopam or SKF 38393) were infused into the renal artery of
anesthetized normotensive Wistar-Kyoto rats (WKY) and
spontaneously hypertensive rats (SHR) (n=5 to 6/drug/strain). Ten or 60
minutes after starting the D1-like agonist infusion, both
the infused kidney and the noninfused kidney that served as control
were prepared for analysis. The D1-like agonists
produced a greater diuresis and natriuresis and inhibited
Na+,K+-ATPase activity in proximal tubule (PT)
and medullary thick ascending limb (mTAL) to a greater extent in WKY
(
20±1%) than in SHR (
7±1%, P<0.001).
D1-like agonists had no effect on PKC-
or PKC-
expression in either membrane or cytosol but increased PKC-
expression in PT in both WKY and SHR at 10 minutes but not at 60
minutes. However, membranous PKC-
expression in PT and mTAL
decreased in WKY but increased in SHR with either 10 or 60 minutes of
D1-like agonist infusion. D1-like agonists also
decreased membranous PKC-
expression in PT and mTAL in WKY but
increased it in PT but not in mTAL in SHR. We conclude that there is
differential regulation of PKC isoform expression by
D1-like agonists that inhibits membranous PKC-
and
PKC-
in WKY but stimulates them in SHR; this effect in SHR is
similar to the stimulatory effect of norepinephrine and
angiotensin II and may be a mechanism for their
differential effects on sodium transport.
Key Words: receptors, dopamine kidney tubules, proximal renal medulla protein kinase C
This article has been cited by other articles:
![]() |
C. S. Escano, I. Armando, X. Wang, L. D. Asico, A. Pascua, Y. Yang, Z. Wang, Y.-S. Lau, and P. A. Jose Renal dopaminergic defect in C57Bl/6J mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1660 - R1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, C. Yu, Y. Han, H. Ren, W. Shi, C. Fu, D. He, L. Huang, C. Yang, X. Wang, et al. Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2761 - H2768. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Asghar, T. Hussain, and M. F. Lokhandwala Overexpression of PKC-{beta}I and -{delta} contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1100 - F1107. [Abstract] [Full Text] |
||||
![]() |
J. Chen, C. Wersinger, and A. Sidhu Chronic Stimulation of D1 Dopamine Receptors in Human SK-N-MC Neuroblastoma Cells Induces Nitric-oxide Synthase Activation and Cytotoxicity J. Biol. Chem., July 18, 2003; 278(30): 28089 - 28100. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hussain and M. F. Lokhandwala Renal Dopamine Receptors and Hypertension Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Li, C. L. Chik, A. K. Ho, and E. Karpinski L-Type Ca2+ Channel Regulation by Pituitary Adenylate Cyclase-Activating Polypeptide in Vascular Myocytes from Spontaneously Hypertensive Rats Endocrinology, July 1, 2001; 142(7): 2865 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. ASGHAR, V. KANSRA, T. HUSSAIN, and M. F. LOKHANDWALA Hyperphosphorylation of Na-Pump Contributes to Defective Renal Dopamine Response in Old Rats J. Am. Soc. Nephrol., February 1, 2001; 12(2): 226 - 232. [Abstract] [Full Text] |
||||
![]() |
E. Feraille and A. Doucet Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control Physiol Rev, January 1, 2001; 81(1): 345 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nowicki, M. S. Kruse, H. Brismar, and A. Aperia Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1812 - C1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yu, L. D. Asico, G. M. Eisner, U. Hopfer, R. A. Felder, and P. A. Jose Renal Protein Phosphatase 2A Activity and Spontaneous Hypertension in Rats Hypertension, December 1, 2000; 36(6): 1053 - 1058. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |